![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/spacer.gif)
| Medicamento usado para controlar el dolor y causar una pérdida temporal de sensibilidad en una parte del cuerpo, durante y después de la cirugía. Asimismo, está en estudio para el control del dolor después de la cirugía del cáncer. Es un tipo de anestésico local. También se llama ropivacaína y Naropin. |
![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20080921123913im_/http://cancernet.nci.nih.gov/images/spacer.gif) |